# C_2009230EN.01001801.xml

| 24.9.2009 | EN | Official Journal of the European Union | C 230/18 |
| --- | --- | --- | --- |

24.9.2009

EN

Official Journal of the European Union

C 230/18

---

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2008

2009/C 230/08

Subcommittee I on the free movement of goods

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July-31 December 2008, at their meeting on 24 April 2009:

| Annex I | List of new marketing authorisations |
| --- | --- |
| Annex II | List of renewed marketing authorisations |
| Annex III | List of extended marketing authorisations |
| Annex IV | List of withdrawn marketing authorisations |
| Annex V | List of suspended marketing authorisations |

Annex I

Annex I

List of new marketing authorisations

Annex II

Annex II

List of renewed marketing authorisations

Annex III

Annex III

List of extended marketing authorisations

Annex IV

Annex IV

List of withdrawn marketing authorisations

Annex V

Annex V

List of suspended marketing authorisations

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July-31 December 2008:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/06/380/001 | Prezista | Liechtenstein | 31.12.2008 |
| EU/1/08/444/001/NO-008/NO | Ratiograstim | Norway | 2.10.2008 |
| EU/1/08/444/001-008 | Ratiograstim | Liechtenstein | 31.10.2008 |
| EU/1/08/444/001-008/IS | Ratiograstim | Iceland | 24.10.2008 |
| EU/1/08/445/001/NO-008/NO | Tevagrastim | Norway | 8.10.2008 |
| EU/1/08/445/001-008 | Tevagrastim | Liechtenstein | 31.10.2008 |
| EU/1/08/445/001-008/IS | Tevagrastim | Iceland | 24.10.2008 |
| EU/1/08/446/001/NO-002/NO | Bridion | Norway | 12.9.2008 |
| EU/1/08/449/001/NO-008/NO | Filgrastim | Norway | 8.10.2008 |
| EU/1/08/449/001-008 | Filgrastim Ratiopharm | Liechtenstein | 31.10.2008 |
| EU/1/08/449/001-008/IS | Filgrastim Ratiopharm | Iceland | 24.10.2008 |
| EU/1/08/450/001/NO-008/NO | Biograstim | Norway | 2.10.2008 |
| EU/1/08/450/001-008 | Biograstim | Liechtenstein | 31.10.2008 |
| EU/1/08/450/001-008/IS | Biograstim | Iceland | 24.10.2008 |
| EU/1/08/452/001/NO | Pandemrix | Norway | 6.8.2008 |
| EU/1/08/453/001/NO | Prepandemrix | Norway | 18.9.2008 |
| EU/1/08/455/001/NO-014/NO | Janumet | Norway | 5.8.2008 |
| EU/1/08/455/001-014 | Janumet | Liechtenstein | 31.8.2008 |
| EU/1/08/455/001-014/IS | Janumet | Iceland | 5.9.2008 |
| EU/1/08/456/001/NO-014/NO | Velmetia | Norway | 5.8.2008 |
| EU/1/08/456/001-014 | Velmetia | Liechtenstein | 31.8.2008 |
| EU/1/08/456/001-014/IS | Velmetia | Iceland | 5.9.2008 |
| EU/1/08/457/001/NO-014/NO | Efficib | Norway | 5.8.2008 |
| EU/1/08/457/001-014 | Efficib | Liechtenstein | 31.8.2008 |
| EU/1/08/457/001-014/IS | Efficib | Iceland | 5.9.2008 |
| EU/1/08/458/001/NO-011/NO | Trevaclyn | Norway | 29.7.2008 |
| EU/1/08/458/001-011 | Trevaclyn | Liechtenstein | 31.8.2008 |
| EU/1/08/458/001-011/IS | Trevaclyn | Iceland | 25.7.2008 |
| EU/1/08/459/001/NO-011/NO | Tredaptive | Norway | 29.7.2008 |
| EU/1/08/459/001-011 | Tredaptive | Liechtenstein | 31.8.2008 |
| EU/1/08/459/001-011/IS | Tredaptive | Iceland | 25.7.2008 |
| EU/1/08/460/001/NO-011/NO | Pelzont | Norway | 29.7.2008 |
| EU/1/08/460/001-011 | Pelzont | Liechtenstein | 31.8.2008 |
| EU/1/08/460/001-011/IS | Pelzont | Iceland | 25.7.2008 |
| EU/1/08/461/001 | Firazyr (orphan drug) | Liechtenstein | 31.8.2008 |
| EU/1/08/461/001/IS | Firazyr | Iceland | 25.7.2008 |
| EU/1/08/461/001/NO | Firazyr | Norway | 25.8.2008 |
| EU/1/08/462/001-006/IS | Latixa | Iceland | 28.7.2008 |
| EU/1/08/463/001/NO-003/NO | Relistor | Norway | 11.7.2008 |
| EU/1/08/463/001-003 | Relistor | Liechtenstein | 31.8.2008 |
| EU/1/08/463/001-003/IS | Relistor | Iceland | 24.7.2008 |
| EU/1/08/464/001/NO-017/NO | Clopidogrel BMS | Norway | 7.8.2008 |
| EU/1/08/464/001-017 | Clopidogrel BMS | Liechtenstein | 31.8.2008 |
| EU/1/08/464/001-017/IS | Clopidogrel BMS | Iceland | 22.9.2008 |
| EU/1/08/465/001/NO-017/NO | Clopidogrel Winthrop | Norway | 7.8.2008 |
| EU/1/08/465/001-017 | Clopidogrel Winthrop | Liechtenstein | 31.8.2008 |
| EU/1/08/465/001-017/IS | Clopidogrel Winthrop | Iceland | 12.9.2008 |
| EU/1/08/466/001-002 | Bridion | Liechtenstein | 31.8.2008 |
| EU/1/08/466/001-002/IS | Bridion | Iceland | 4.9.2008 |
| EU/1/08/467/001 | Doribax | Liechtenstein | 31.8.2008 |
| EU/1/08/467/001/IS | Doribax | Iceland | 8.9.2008 |
| EU/1/08/467/001/NO | Doribax | Norway | 1.9.2008 |
| EU/1/08/468/001 | Intelence | Liechtenstein | 31.10.2008 |
| EU/1/08/468/001/IS | Intelence | Iceland | 26.9.2008 |
| EU/1/08/468/001/NO | Intelence | Norway | 18.9.2008 |
| EU/1/08/468/001/NO-025/NO | Oprymea | Norway | 9.10.2008 |
| EU/1/08/469/001-025 | Oprymea | Liechtenstein | 31.10.2008 |
| EU/1/08/469/001-025/IS | Oprymea | Iceland | 27.10.2008 |
| EU/1/08/470/001/NO-016/NO | Vimpat | Norway | 22.9.2008 |
| EU/1/08/470/001-015/IS | Vimpat | Iceland | 10.9.2008 |
| EU/1/08/470/001-016 | Vimpat | Liechtenstein | 31.10.2008 |
| EU/1/08/471/001/NO-012/NO | Duloxetine Boehringer Ingelheim | Norway | 29.10.2008 |
| EU/1/08/471/001-012 | Duloxetine Boehringer Ingelheim | Liechtenstein | 31.10.2008 |
| EU/1/08/471/001-012/IS | Duloxetine Boehringer Ingelheim | Iceland | 7.11.2008 |
| EU/1/08/472/001/NO-008/NO | Xarelto | Norway | 9.10.2008 |
| EU/1/08/472/001-008 | Xarelto | Liechtenstein | 31.10.2008 |
| EU/1/08/472/001-008/IS | Xarelto | Iceland | 15.10.2008 |
| EU/1/08/473/001/NO-003/NO | Evicel | Norway | 28.10.2008 |
| EU/1/08/473/001-003 | Evicel | Liechtenstein | 31.10.2008 |
| EU/1/08/473/001-003/IS | Evicel | Iceland | 17.11.2008 |
| EU/1/08/474/001-003 | Fluticasone furoate GSK | Liechtenstein | 31.10.2008 |
| EU/1/08/475/001/NO-034/NO | Olanzapine Mylan | Norway | 29.10.2008 |
| EU/1/08/475/001-034 | Olanzapine Mylan | Liechtenstein | 31.10.2008 |
| EU/1/08/475/001-034/IS | Olanzapine Mylan | Iceland | 21.11.2008 |
| EU/1/08/476/001/NO-004/NO | Tadalafil | Norway | 23.10.2008 |
| EU/1/08/476/001-004 | Tadalafil Lilly | Liechtenstein | 31.10.2008 |
| EU/1/08/477/001 | Ceplene (orphan) | Liechtenstein | 31.10.2008 |
| EU/1/08/477/001/IS | Ceplene | Iceland | 19.11.2008 |
| EU/1/08/478/001 | Prepandemic influenza vaccine (H5N1) | Liechtenstein | 31.10.2008 |
| EU/1/08/478/001/IS | Prepandemic influenza vaccine (H5N1) | Iceland | 24.10.2008 |
| EU/1/08/478/001/NO | Prepandemic influenza vaccine | Norway | 4.12.2008 |
| EU/1/08/479/001/NO-003/NO | Zypadhera | Norway | 16.12.2008 |
| EU/1/08/479/001-003 | Zypadhera | Liechtenstein | 31.12.2008 |
| EU/1/08/479/001-003/IS | Zypadhera | Iceland | 16.12.2008 |
| EU/1/08/480/001-018 | Irbesartan Krka | Liechtenstein | 31.12.2008 |
| EU/1/08/481/001-003 | Kuvan (orphan drug) | Liechtenstein | 31.12.2008 |
| EU/1/08/482/001-002 | Azarga | Liechtenstein | 31.12.2008 |
| EU/1/08/483/001-018 | Zomarist | Liechtenstein | 31.12.2008 |
| EU/1/08/484/001-018 | Vildagliptin | Liechtenstein | 31.12.2008 |
| EU/1/08/485/001/NO-011/NO | Jalra | Norway | 4.12.2008 |
| EU/1/08/485/001-011 | Jalra | Liechtenstein | 31.12.2008 |
| EU/1/08/485/001-011/IS | Jalra | Iceland | 16.12.2008 |
| EU/1/08/486/001/NO-011/NO | Xiliarx | Norway | 4.12.2008 |
| EU/1/08/486/001-011 | Xiliarx | Liechtenstein | 31.12.2008 |
| EU/1/08/486/001-011/IS | Xiliarx | Iceland | 16.12.2008 |
| EU/1/08477/001/NO | Ceplene | Norway | 28.10.2008 |
| EU/2/08/080/001-004 | Reconcile | Liechtenstein | 31.8.2008 |
| EU/2/08/080/001-004/IS | Reconcile | Iceland | 5.8.2008 |
| EU/2/08/081/001-003/IS | Posatex | Iceland | 10.9.2008 |
| EU/2/08/082/001-003 | Zactran | Liechtenstein | 31.8.2008 |
| EU/2/08/082/001-003/IS | Zactran | Iceland | 8.9.2008 |
| EU/2/08/083/001 | Equioxx | Liechtenstein | 31.8.2008 |
| EU/2/08/084/001/NO-005/NO | Trocoxil | Norway | 15.10.2008 |
| EU/2/08/084/001-005 | Trocoxil | Liechtenstein | 31.10.2008 |
| EU/2/08/084/001-005/IS | Trocoxil | Iceland | 24.10.2008 |
| EU/2/08/085/001 | Easotic | Liechtenstein | 31.12.2008 |
| EU/2/08/086/001/NO-003/NO | Duvaxyn WNV | Norway | 18.12.2008 |
| EU/2/08/086/001-003 | Duvaxyn WNV | Liechtenstein | 31.12.2008 |
| EU/2/08/087/001-002 | Masivet | Liechtenstein | 31.12.2008 |
| EU/2/08/087/001-002/IS | Masivet | Iceland | 12.12.2008 |
| EU/2/08/088/001-004 | Acticam | Liechtenstein | 31.12.2008 |

EU-Number

Product

Country

Date of authorisation

EU/1/06/380/001

Prezista

Liechtenstein

31.12.2008

EU/1/08/444/001/NO-008/NO

Ratiograstim

Norway

2.10.2008

EU/1/08/444/001-008

Ratiograstim

Liechtenstein

31.10.2008

EU/1/08/444/001-008/IS

Ratiograstim

Iceland

24.10.2008

EU/1/08/445/001/NO-008/NO

Tevagrastim

Norway

8.10.2008

EU/1/08/445/001-008

Tevagrastim

Liechtenstein

31.10.2008

EU/1/08/445/001-008/IS

Tevagrastim

Iceland

24.10.2008

EU/1/08/446/001/NO-002/NO

Bridion

Norway

12.9.2008

EU/1/08/449/001/NO-008/NO

Filgrastim

Norway

8.10.2008

EU/1/08/449/001-008

Filgrastim Ratiopharm

Liechtenstein

31.10.2008

EU/1/08/449/001-008/IS

Filgrastim Ratiopharm

Iceland

24.10.2008

EU/1/08/450/001/NO-008/NO

Biograstim

Norway

2.10.2008

EU/1/08/450/001-008

Biograstim

Liechtenstein

31.10.2008

EU/1/08/450/001-008/IS

Biograstim

Iceland

24.10.2008

EU/1/08/452/001/NO

Pandemrix

Norway

6.8.2008

EU/1/08/453/001/NO

Prepandemrix

Norway

18.9.2008

EU/1/08/455/001/NO-014/NO

Janumet

Norway

5.8.2008

EU/1/08/455/001-014

Janumet

Liechtenstein

31.8.2008

EU/1/08/455/001-014/IS

Janumet

Iceland

5.9.2008

EU/1/08/456/001/NO-014/NO

Velmetia

Norway

5.8.2008

EU/1/08/456/001-014

Velmetia

Liechtenstein

31.8.2008

EU/1/08/456/001-014/IS

Velmetia

Iceland

5.9.2008

EU/1/08/457/001/NO-014/NO

Efficib

Norway

5.8.2008

EU/1/08/457/001-014

Efficib

Liechtenstein

31.8.2008

EU/1/08/457/001-014/IS

Efficib

Iceland

5.9.2008

EU/1/08/458/001/NO-011/NO

Trevaclyn

Norway

29.7.2008

EU/1/08/458/001-011

Trevaclyn

Liechtenstein

31.8.2008

EU/1/08/458/001-011/IS

Trevaclyn

Iceland

25.7.2008

EU/1/08/459/001/NO-011/NO

Tredaptive

Norway

29.7.2008

EU/1/08/459/001-011

Tredaptive

Liechtenstein

31.8.2008

EU/1/08/459/001-011/IS

Tredaptive

Iceland

25.7.2008

EU/1/08/460/001/NO-011/NO

Pelzont

Norway

29.7.2008

EU/1/08/460/001-011

Pelzont

Liechtenstein

31.8.2008

EU/1/08/460/001-011/IS

Pelzont

Iceland

25.7.2008

EU/1/08/461/001

Firazyr (orphan drug)

Liechtenstein

31.8.2008

EU/1/08/461/001/IS

Firazyr

Iceland

25.7.2008

EU/1/08/461/001/NO

Firazyr

Norway

25.8.2008

EU/1/08/462/001-006/IS

Latixa

Iceland

28.7.2008

EU/1/08/463/001/NO-003/NO

Relistor

Norway

11.7.2008

EU/1/08/463/001-003

Relistor

Liechtenstein

31.8.2008

EU/1/08/463/001-003/IS

Relistor

Iceland

24.7.2008

EU/1/08/464/001/NO-017/NO

Clopidogrel BMS

Norway

7.8.2008

EU/1/08/464/001-017

Clopidogrel BMS

Liechtenstein

31.8.2008

EU/1/08/464/001-017/IS

Clopidogrel BMS

Iceland

22.9.2008

EU/1/08/465/001/NO-017/NO

Clopidogrel Winthrop

Norway

7.8.2008

EU/1/08/465/001-017

Clopidogrel Winthrop

Liechtenstein

31.8.2008

EU/1/08/465/001-017/IS

Clopidogrel Winthrop

Iceland

12.9.2008

EU/1/08/466/001-002

Bridion

Liechtenstein

31.8.2008

EU/1/08/466/001-002/IS

Bridion

Iceland

4.9.2008

EU/1/08/467/001

Doribax

Liechtenstein

31.8.2008

EU/1/08/467/001/IS

Doribax

Iceland

8.9.2008

EU/1/08/467/001/NO

Doribax

Norway

1.9.2008

EU/1/08/468/001

Intelence

Liechtenstein

31.10.2008

EU/1/08/468/001/IS

Intelence

Iceland

26.9.2008

EU/1/08/468/001/NO

Intelence

Norway

18.9.2008

EU/1/08/468/001/NO-025/NO

Oprymea

Norway

9.10.2008

EU/1/08/469/001-025

Oprymea

Liechtenstein

31.10.2008

EU/1/08/469/001-025/IS

Oprymea

Iceland

27.10.2008

EU/1/08/470/001/NO-016/NO

Vimpat

Norway

22.9.2008

EU/1/08/470/001-015/IS

Vimpat

Iceland

10.9.2008

EU/1/08/470/001-016

Vimpat

Liechtenstein

31.10.2008

EU/1/08/471/001/NO-012/NO

Duloxetine Boehringer Ingelheim

Norway

29.10.2008

EU/1/08/471/001-012

Duloxetine Boehringer Ingelheim

Liechtenstein

31.10.2008

EU/1/08/471/001-012/IS

Duloxetine Boehringer Ingelheim

Iceland

7.11.2008

EU/1/08/472/001/NO-008/NO

Xarelto

Norway

9.10.2008

EU/1/08/472/001-008

Xarelto

Liechtenstein

31.10.2008

EU/1/08/472/001-008/IS

Xarelto

Iceland

15.10.2008

EU/1/08/473/001/NO-003/NO

Evicel

Norway

28.10.2008

EU/1/08/473/001-003

Evicel

Liechtenstein

31.10.2008

EU/1/08/473/001-003/IS

Evicel

Iceland

17.11.2008

EU/1/08/474/001-003

Fluticasone furoate GSK

Liechtenstein

31.10.2008

EU/1/08/475/001/NO-034/NO

Olanzapine Mylan

Norway

29.10.2008

EU/1/08/475/001-034

Olanzapine Mylan

Liechtenstein

31.10.2008

EU/1/08/475/001-034/IS

Olanzapine Mylan

Iceland

21.11.2008

EU/1/08/476/001/NO-004/NO

Tadalafil

Norway

23.10.2008

EU/1/08/476/001-004

Tadalafil Lilly

Liechtenstein

31.10.2008

EU/1/08/477/001

Ceplene (orphan)

Liechtenstein

31.10.2008

EU/1/08/477/001/IS

Ceplene

Iceland

19.11.2008

EU/1/08/478/001

Prepandemic influenza vaccine (H5N1)

Liechtenstein

31.10.2008

EU/1/08/478/001/IS

Prepandemic influenza vaccine (H5N1)

Iceland

24.10.2008

EU/1/08/478/001/NO

Prepandemic influenza vaccine

Norway

4.12.2008

EU/1/08/479/001/NO-003/NO

Zypadhera

Norway

16.12.2008

EU/1/08/479/001-003

Zypadhera

Liechtenstein

31.12.2008

EU/1/08/479/001-003/IS

Zypadhera

Iceland

16.12.2008

EU/1/08/480/001-018

Irbesartan Krka

Liechtenstein

31.12.2008

EU/1/08/481/001-003

Kuvan (orphan drug)

Liechtenstein

31.12.2008

EU/1/08/482/001-002

Azarga

Liechtenstein

31.12.2008

EU/1/08/483/001-018

Zomarist

Liechtenstein

31.12.2008

EU/1/08/484/001-018

Vildagliptin

Liechtenstein

31.12.2008

EU/1/08/485/001/NO-011/NO

Jalra

Norway

4.12.2008

EU/1/08/485/001-011

Jalra

Liechtenstein

31.12.2008

EU/1/08/485/001-011/IS

Jalra

Iceland

16.12.2008

EU/1/08/486/001/NO-011/NO

Xiliarx

Norway

4.12.2008

EU/1/08/486/001-011

Xiliarx

Liechtenstein

31.12.2008

EU/1/08/486/001-011/IS

Xiliarx

Iceland

16.12.2008

EU/1/08477/001/NO

Ceplene

Norway

28.10.2008

EU/2/08/080/001-004

Reconcile

Liechtenstein

31.8.2008

EU/2/08/080/001-004/IS

Reconcile

Iceland

5.8.2008

EU/2/08/081/001-003/IS

Posatex

Iceland

10.9.2008

EU/2/08/082/001-003

Zactran

Liechtenstein

31.8.2008

EU/2/08/082/001-003/IS

Zactran

Iceland

8.9.2008

EU/2/08/083/001

Equioxx

Liechtenstein

31.8.2008

EU/2/08/084/001/NO-005/NO

Trocoxil

Norway

15.10.2008

EU/2/08/084/001-005

Trocoxil

Liechtenstein

31.10.2008

EU/2/08/084/001-005/IS

Trocoxil

Iceland

24.10.2008

EU/2/08/085/001

Easotic

Liechtenstein

31.12.2008

EU/2/08/086/001/NO-003/NO

Duvaxyn WNV

Norway

18.12.2008

EU/2/08/086/001-003

Duvaxyn WNV

Liechtenstein

31.12.2008

EU/2/08/087/001-002

Masivet

Liechtenstein

31.12.2008

EU/2/08/087/001-002/IS

Masivet

Iceland

12.12.2008

EU/2/08/088/001-004

Acticam

Liechtenstein

31.12.2008

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July-31 December 2008:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/00/162/003/NO-005/NO;
  EU/1/00/162/009/NO-011/NO;
  EU/1/00/162/015/NO-017/NO;
  EU/1/00/162/019/NO-021/NO | Prandin | Norway | 15.8.2008 |
| EU/1/00/162/003-005, 009-011, 015-017, 019-021 | Prandin | Liechtenstein | 31.8.2008 |
| EU/1/00/162/003-005, 009-011, 015-017, 019-021/IS | Prandin | Iceland | 26.9.2008 |
| EU/1/03/247/001/NO-002/NO | Forsteo | Norway | 1.7.2008 |
| EU/1/03/252/001/NO-003/NO | Fuzeon | Norway | 12.8.2008 |
| EU/1/03/252/001-003 | Fuzeon | Liechtenstein | 31.8.2008 |
| EU/1/03/252/001-003/IS | Fuzeon | Iceland | 5.8.2008 |
| EU/1/03/254/002 | Busilvex | Liechtenstein | 31.8.2008 |
| EU/1/03/254/002/IS | Busilvex | Iceland | 10.7.2008 |
| EU/1/03/254/002/NO | Busilvex | Norway | 12.8.2008 |
| EU/1/03/255/001/NO-006/NO | Ventavis | Norway | 29.9.2008 |
| EU/1/03/255/001-006 | Ventavis | Liechtenstein | 31.10.2008 |
| EU/1/03/255/001-006/IS | Ventavis | Iceland | 19.10.2008 |
| EU/1/03/256/001/NO-010/NO | Humira | Norway | 25.9.2008 |
| EU/1/03/256/001-010 | Humira | Liechtenstein | 31.10.2008 |
| EU/1/03/256/001-010/IS | Humira | Iceland | 24.10.2008 |
| EU/1/03/258/001/NO-022/NO | Avandamet | Norway | 9.9.2008 |
| EU/1/03/258/001-022 | Avandamet | Liechtenstein | 31.8.2008 |
| EU/1/03/258/001-022/IS | Avandamet | Iceland | 20.10.2008 |
| EU/1/03/259/001/NO-006/NO | Onsenal | Norway | 6.11.2008 |
| EU/1/03/259/001-006 | Onsenal | Liechtenstein | 31.10.2008 |
| EU/1/03/259/001-006/IS | Onsenal | Iceland | 12.12.2008 |
| EU/1/03/260/001/NO-023/NO | Stalevo | Norway | 9.10.2008 |
| EU/1/03/260/001-023 | Stalevo | Liechtenstein | 31.10.2008 |
| EU/1/03/260/001-023/IS | Stalevo | Iceland | 22.10.2008 |
| EU/1/03/261/001/NO-003/NO | Emtriva | Norway | 10.11.2008 |
| EU/1/03/261/001-003 | Emtriva | Liechtenstein | 31.10.2008 |
| EU/1/03/261/001-003/IS | Emtriva | Iceland | 27.10.2008 |
| EU/1/03/262/001/NO-008/NO | Emend | Norway | 8.10.2008 |
| EU/1/03/262/001-008 | Emend | Liechtenstein | 31.10.2008 |
| EU/1/03/262/001-008/IS | Emend | Iceland | 27.10.2008 |
| EU/1/03/269/001 | Faslodex | Liechtenstein | 31.12.2008 |
| EU/1/06/367/001-012 | Diacomit | Liechtenstein | 31.12.2008 |
| EU/1/06/367/001-012/IS | Diacomit | Iceland | 18.12.2008 |
| EU/1/07/436/001-002 | Isentress | Liechtenstein | 31.12.2008 |
| EU/1/07/436/001-002/IS | Isentress | Iceland | 18.12.2008 |
| EU/1/98/064/001 | Pylobactell | Liechtenstein | 31.8.2008 |
| EU/1/98/064/001/IS | Pylobactell | Iceland | 19.10.2008 |
| EU/1/98/064/001/NO | Pylobactell | Norway | 8.12.2008 |
| EU/1/98/065/001/NO-002/NO | Optison | Norway | 18.9.2008 |
| EU/1/98/065/001-002/IS | Optison | Iceland | 10.7.2008 |
| EU/1/98/069/001a/NO-007a/NO;
  EU/1/98/069/001b/NO-007b/NO
  EU/1/98/069/008/NO-010/NO | Plavix | Norway | 2.7.2008 |
| EU/1/98/070/001a/NO-007a/NO;
  EU/1/98/070/001b/NO-007b/NO;
  EU/1/98/070/008/NO-010/NO | Iscover | Norway | 2.7.2008 |
| EU/1/98/071/001/NO-006/NO | Xenical | Norway | 9.9.2008 |
| EU/1/98/071/001-006/IS | Xenical | Iceland | 10.7.2008 |
| EU/1/98/073/001/NO-004/NO | Evista | Norway | 19.9.2008 |
| EU/1/98/073/001-004 | Evista | Liechtenstein | 31.8.2008 |
| EU/1/98/073/001-004/IS | Evista | Iceland | 22.10.2008 |
| EU/1/98/074/001/NO-004/NO | Optruma | Norway | 19.9.2008 |
| EU/1/98/074/001-004 | Optruma | Liechtenstein | 31.8.2008 |
| EU/1/98/074/001-004/IS | Optruma | Iceland | 22.10.2008 |
| EU/1/98/076/004/NO-006/NO,
  EU/1/98/076/011/NO-013/NO,
  EU/1/98/076/018/NO-020/NO,
  EU/1/98/076/022/NO-024/NO | NovoNorm | Norway | 15.8.2008 |
| EU/1/98/076/004-006, 011-013, 018-020, 022-024 | NovoNorm | Liechtenstein | 31.8.2008 |
| EU/1/98/076/004-006, 011-013, 018-020, 022-024/IS | NovoNorm | Iceland | 25.9.2008 |
| EU/1/98/077/002/NO-004/NO;
  EU/1/98/077/006/NO-008/NO;
  EU/1/98/077/010/NO-019/NO | Viagra | Norway | 24.9.2008 |
| EU/1/98/077/002-004, 006-008, 010-019/IS | Viagra | Iceland | 25.10.2008 |
| EU/1/98/080/001 | Aldara | Liechtenstein | 31.10.2008 |
| EU/1/98/080/001/IS | Aldara | Iceland | 19.11.2008 |
| EU/1/98/080/001/NO | Aldara | Norway | 9.10.2008 |
| EU/1/98/081/001/NO-004/NO | Comtan | Norway | 29.9.2008 |
| EU/1/98/081/001-004 | Comtan | Liechtenstein | 31.10.2008 |
| EU/1/98/081/001-004/IS | Comtan | Iceland | 21.10.2008 |
| EU/1/98/082/001/NO-003/NO;
  EU/1/98/082/005/NO | Comtess | Norway | 29.9.2008 |
| EU/1/98/082/001-003, 005 | Comtess | Liechtenstein | 31.10.2008 |
| EU/1/98/082/001-003, 005/IS | Comtess | Iceland | 21.10.2008 |
| EU/1/98/084/001/NO-002/NO | Simulect | Norway | 11.11.2008 |
| EU/1/98/084/001-002 | Simulect | Liechtenstein | 31.10.2008 |
| EU/1/98/084/001-002/IS | Simulect | Iceland | 7.11.2008 |
| EU/1/98/085/001/NO-034/NO | Karvezide | Norway | 28.10.2008 |
| EU/1/98/085/001-034 | Karvezide | Liechtenstein | 31.12.2008 |
| EU/1/98/085/001-034/IS | Karvezide | Iceland | 28.10.2008 |
| EU/1/98/086/001/NO-034/NO | CoAprovel | Norway | 28.10.2008 |
| EU/1/98/086/001-034 | CoAprovel | Liechtenstein | 31.12.2008 |
| EU/1/98/086/001-034/IS | CoAprovel | Iceland | 28.10.2008 |
| EU/1/98/089/001-022 | Pritor | Liechtenstein | 31.12.2008 |
| EU/1/98/089/001-022/IS | Pritor | Iceland | 18.12.2008 |
| EU/1/98/090/001-020 | Micardis | Liechtenstein | 31.12.2008 |
| EU/1/98/090/001-020/IS | Micardis | Iceland | 18.12.2008 |
| EU/1/98/091/001-014 | Kinzalmono | Liechtenstein | 31.12.2008 |
| EU/1/98/091/001-014/IS | Kinzalmono | Iceland | 18.12.2008 |
| EU/2/03/040/001-002/IS | Gonazon | Iceland | 11.7.2008 |
| EU/2/03/041/001-005 | Draxxin | Liechtenstein | 31.10.2008 |
| EU/2/03/041/001-005/IS | Draxxin | Iceland | 27.10.2008 |
| EU/2/98/009/001/NO-006/NO | Suvaxyn Aujeszky | Norway | 18.12.2008 |
| EU/2/98/009/001-006 | Suvaxyn Aujeszky | Liechtenstein | 31.10.2008 |
| EU/2/99/011/001 | Locatim | Liechtenstein | 31.12.2008 |

EU-Number

Product

Country

Date of authorisation

EU/1/00/162/003/NO-005/NO;

EU/1/00/162/009/NO-011/NO;

EU/1/00/162/015/NO-017/NO;

EU/1/00/162/019/NO-021/NO

Prandin

Norway

15.8.2008

EU/1/00/162/003-005, 009-011, 015-017, 019-021

Prandin

Liechtenstein

31.8.2008

EU/1/00/162/003-005, 009-011, 015-017, 019-021/IS

Prandin

Iceland

26.9.2008

EU/1/03/247/001/NO-002/NO

Forsteo

Norway

1.7.2008

EU/1/03/252/001/NO-003/NO

Fuzeon

Norway

12.8.2008

EU/1/03/252/001-003

Fuzeon

Liechtenstein

31.8.2008

EU/1/03/252/001-003/IS

Fuzeon

Iceland

5.8.2008

EU/1/03/254/002

Busilvex

Liechtenstein

31.8.2008

EU/1/03/254/002/IS

Busilvex

Iceland

10.7.2008

EU/1/03/254/002/NO

Busilvex

Norway

12.8.2008

EU/1/03/255/001/NO-006/NO

Ventavis

Norway

29.9.2008

EU/1/03/255/001-006

Ventavis

Liechtenstein

31.10.2008

EU/1/03/255/001-006/IS

Ventavis

Iceland

19.10.2008

EU/1/03/256/001/NO-010/NO

Humira

Norway

25.9.2008

EU/1/03/256/001-010

Humira

Liechtenstein

31.10.2008

EU/1/03/256/001-010/IS

Humira

Iceland

24.10.2008

EU/1/03/258/001/NO-022/NO

Avandamet

Norway

9.9.2008

EU/1/03/258/001-022

Avandamet

Liechtenstein

31.8.2008

EU/1/03/258/001-022/IS

Avandamet

Iceland

20.10.2008

EU/1/03/259/001/NO-006/NO

Onsenal

Norway

6.11.2008

EU/1/03/259/001-006

Onsenal

Liechtenstein

31.10.2008

EU/1/03/259/001-006/IS

Onsenal

Iceland

12.12.2008

EU/1/03/260/001/NO-023/NO

Stalevo

Norway

9.10.2008

EU/1/03/260/001-023

Stalevo

Liechtenstein

31.10.2008

EU/1/03/260/001-023/IS

Stalevo

Iceland

22.10.2008

EU/1/03/261/001/NO-003/NO

Emtriva

Norway

10.11.2008

EU/1/03/261/001-003

Emtriva

Liechtenstein

31.10.2008

EU/1/03/261/001-003/IS

Emtriva

Iceland

27.10.2008

EU/1/03/262/001/NO-008/NO

Emend

Norway

8.10.2008

EU/1/03/262/001-008

Emend

Liechtenstein

31.10.2008

EU/1/03/262/001-008/IS

Emend

Iceland

27.10.2008

EU/1/03/269/001

Faslodex

Liechtenstein

31.12.2008

EU/1/06/367/001-012

Diacomit

Liechtenstein

31.12.2008

EU/1/06/367/001-012/IS

Diacomit

Iceland

18.12.2008

EU/1/07/436/001-002

Isentress

Liechtenstein

31.12.2008

EU/1/07/436/001-002/IS

Isentress

Iceland

18.12.2008

EU/1/98/064/001

Pylobactell

Liechtenstein

31.8.2008

EU/1/98/064/001/IS

Pylobactell

Iceland

19.10.2008

EU/1/98/064/001/NO

Pylobactell

Norway

8.12.2008

EU/1/98/065/001/NO-002/NO

Optison

Norway

18.9.2008

EU/1/98/065/001-002/IS

Optison

Iceland

10.7.2008

EU/1/98/069/001a/NO-007a/NO;

EU/1/98/069/001b/NO-007b/NO

EU/1/98/069/008/NO-010/NO

Plavix

Norway

2.7.2008

EU/1/98/070/001a/NO-007a/NO;

EU/1/98/070/001b/NO-007b/NO;

EU/1/98/070/008/NO-010/NO

Iscover

Norway

2.7.2008

EU/1/98/071/001/NO-006/NO

Xenical

Norway

9.9.2008

EU/1/98/071/001-006/IS

Xenical

Iceland

10.7.2008

EU/1/98/073/001/NO-004/NO

Evista

Norway

19.9.2008

EU/1/98/073/001-004

Evista

Liechtenstein

31.8.2008

EU/1/98/073/001-004/IS

Evista

Iceland

22.10.2008

EU/1/98/074/001/NO-004/NO

Optruma

Norway

19.9.2008

EU/1/98/074/001-004

Optruma

Liechtenstein

31.8.2008

EU/1/98/074/001-004/IS

Optruma

Iceland

22.10.2008

EU/1/98/076/004/NO-006/NO,

EU/1/98/076/011/NO-013/NO,

EU/1/98/076/018/NO-020/NO,

EU/1/98/076/022/NO-024/NO

NovoNorm

Norway

15.8.2008

EU/1/98/076/004-006, 011-013, 018-020, 022-024

NovoNorm

Liechtenstein

31.8.2008

EU/1/98/076/004-006, 011-013, 018-020, 022-024/IS

NovoNorm

Iceland

25.9.2008

EU/1/98/077/002/NO-004/NO;

EU/1/98/077/006/NO-008/NO;

EU/1/98/077/010/NO-019/NO

Viagra

Norway

24.9.2008

EU/1/98/077/002-004, 006-008, 010-019/IS

Viagra

Iceland

25.10.2008

EU/1/98/080/001

Aldara

Liechtenstein

31.10.2008

EU/1/98/080/001/IS

Aldara

Iceland

19.11.2008

EU/1/98/080/001/NO

Aldara

Norway

9.10.2008

EU/1/98/081/001/NO-004/NO

Comtan

Norway

29.9.2008

EU/1/98/081/001-004

Comtan

Liechtenstein

31.10.2008

EU/1/98/081/001-004/IS

Comtan

Iceland

21.10.2008

EU/1/98/082/001/NO-003/NO;

EU/1/98/082/005/NO

Comtess

Norway

29.9.2008

EU/1/98/082/001-003, 005

Comtess

Liechtenstein

31.10.2008

EU/1/98/082/001-003, 005/IS

Comtess

Iceland

21.10.2008

EU/1/98/084/001/NO-002/NO

Simulect

Norway

11.11.2008

EU/1/98/084/001-002

Simulect

Liechtenstein

31.10.2008

EU/1/98/084/001-002/IS

Simulect

Iceland

7.11.2008

EU/1/98/085/001/NO-034/NO

Karvezide

Norway

28.10.2008

EU/1/98/085/001-034

Karvezide

Liechtenstein

31.12.2008

EU/1/98/085/001-034/IS

Karvezide

Iceland

28.10.2008

EU/1/98/086/001/NO-034/NO

CoAprovel

Norway

28.10.2008

EU/1/98/086/001-034

CoAprovel

Liechtenstein

31.12.2008

EU/1/98/086/001-034/IS

CoAprovel

Iceland

28.10.2008

EU/1/98/089/001-022

Pritor

Liechtenstein

31.12.2008

EU/1/98/089/001-022/IS

Pritor

Iceland

18.12.2008

EU/1/98/090/001-020

Micardis

Liechtenstein

31.12.2008

EU/1/98/090/001-020/IS

Micardis

Iceland

18.12.2008

EU/1/98/091/001-014

Kinzalmono

Liechtenstein

31.12.2008

EU/1/98/091/001-014/IS

Kinzalmono

Iceland

18.12.2008

EU/2/03/040/001-002/IS

Gonazon

Iceland

11.7.2008

EU/2/03/041/001-005

Draxxin

Liechtenstein

31.10.2008

EU/2/03/041/001-005/IS

Draxxin

Iceland

27.10.2008

EU/2/98/009/001/NO-006/NO

Suvaxyn Aujeszky

Norway

18.12.2008

EU/2/98/009/001-006

Suvaxyn Aujeszky

Liechtenstein

31.10.2008

EU/2/99/011/001

Locatim

Liechtenstein

31.12.2008

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July-31 December 2008:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/01/183/030-032 | HBVAXPRO | Liechtenstein | 31.10.2008 |
| EU/1/01/195/022-027 | Liprolog | Liechtenstein | 31.8.2008 |
| EU/1/01/195/022-027/IS | Liprolog | Iceland | 11.8.2008 |
| EU/1/02/214/011/NO-015/NO | Kinzalkomb | Norway | 15.9.2008 |
| EU/1/02/215/015/NO-021/NO | PritorPlus | Norway | 15.9.2008 |
| EU/1/03/255/006 | Ventavis | Liechtenstein | 31.8.2008 |
| EU/1/03/267/010 | Reyataz | Liechtenstein | 31.12.2008 |
| EU/1/04/291/003 | Raptiva | Liechtenstein | 31.10.2008 |
| EU/1/04/291/003/NO | Raptiva | Norway | 26.11.2008 |
| EU/1/04/305/002 | Truvada | Liechtenstein | 31.10.2008 |
| EU/1/04/305/002/NO | Truvada | Norway | 16.9.2008 |
| EU/1/05/330/005/NO-011/NO | Rotarix | Norway | 6.10.2008 |
| EU/1/05/330/005-011 | Rotarix | Liechtenstein | 31.10.2008 |
| EU/1/05/330/005-011/IS | Rotarix | Iceland | 27.9.2008 |
| EU/1/05/331/038/NO-055/NO | Neupro | Norway | 25.9.2008 |
| EU/1/05/331/038-055 | Neupro | Liechtenstein | 31.10.2008 |
| EU/1/05/331/038-055/IS | Neupro | Iceland | 15.10.2008 |
| EU/1/06/343/006-007 | Baraclude | Liechtenstein | 31.8.2008 |
| EU/1/06/356/007-009 | Exjade | Liechtenstein | 31.12.2008 |
| EU/1/06/360/012 | Champix | Liechtenstein | 31.8.2008 |
| EU/1/06/368/088/NO-142/NO | Insulin Human Winthrop | Norway | 28.11.2008 |
| EU/1/06/368/088-142 | Insulin Human Winthrop | Liechtenstein | 31.12.2008 |
| EU/1/07/386/011-012 | Toviaz | Liechtenstein | 31.8.2008 |
| EU/1/07/386/013-016 | Toviaz | Liechtenstein | 31.12.2008 |
| EU/1/07/392/002 | Circadin | Liechtenstein | 31.8.2008 |
| EU/1/07/394/007-009 | Optaflu | Liechtenstein | 31.8.2008 |
| EU/1/07/400/017/NO-021/NO | Mircera | Norway | 13.10.2008 |
| EU/1/07/400/017-020/IS | Mircera | Iceland | 17.10.2008 |
| EU/1/07/400/017-021 | Mircera | Liechtenstein | 31.10.2008 |
| EU/1/07/410/017-020 | Binocrit | Liechtenstein | 31.8.2008 |
| EU/1/07/411/017-020 | Epoetin alfa Hexal | Liechtenstein | 31.8.2008 |
| EU/1/07/412/017-020 | Abseamed | Liechtenstein | 31.8.2008 |
| EU/1/07/414/018 | Galvus | Liechtenstein | 31.10.2008 |
| EU/1/07/419/010-012 | Cervarix | Liechtenstein | 31.12.2008 |
| EU/1/07/431/020/NO-025/NO | Retacrit | Norway | 15.12.2008 |
| EU/1/07/431/020-025 | Retacrit | Liechtenstein | 31.12.2008 |
| EU/1/07/432/020-022 | Silapo | Liechtenstein | 31.8.2008 |
| EU/1/95/003/007/NO-008/NO | Betaferon | Norway | 13.11.2008 |
| EU/1/95/003/007-008 | Betaferon | Liechtenstein | 31.12.2008 |
| EU/1/97/030/140/NO-169/NO | Insuman | Norway | 1.12.2008 |
| EU/1/97/030/140-169 | Insuman | Liechtenstein | 31.12.2008 |
| EU/102/206/021/NO-035/NO | Arixtra | Norway | 8.9.2008 |
| EU/102/206/021-035 | Arixtra | Liechtenstein | 31.10.2008 |
| EU/2/02/033/002 | Dexdomitor | Liechtenstein | 31.8.2008 |
| EU/2/05/054/018/NO-031/NO | Profender | Norway | 24.9.2008 |
| EU/2/05/054/018-031 | Profender | Liechtenstein | 31.10.2008 |
| EU/2/05/054/018-031/IS | Profender | Iceland | 1.10.2008 |
| EU/2/06/058/004 | Flexicam | Liechtenstein | 31.12.2008 |
| EU/2/99/015/002 | Oxyglobin | Liechtenstein | 31.10.2008 |

EU-Number

Product

Country

Date of authorisation

EU/1/01/183/030-032

HBVAXPRO

Liechtenstein

31.10.2008

EU/1/01/195/022-027

Liprolog

Liechtenstein

31.8.2008

EU/1/01/195/022-027/IS

Liprolog

Iceland

11.8.2008

EU/1/02/214/011/NO-015/NO

Kinzalkomb

Norway

15.9.2008

EU/1/02/215/015/NO-021/NO

PritorPlus

Norway

15.9.2008

EU/1/03/255/006

Ventavis

Liechtenstein

31.8.2008

EU/1/03/267/010

Reyataz

Liechtenstein

31.12.2008

EU/1/04/291/003

Raptiva

Liechtenstein

31.10.2008

EU/1/04/291/003/NO

Raptiva

Norway

26.11.2008

EU/1/04/305/002

Truvada

Liechtenstein

31.10.2008

EU/1/04/305/002/NO

Truvada

Norway

16.9.2008

EU/1/05/330/005/NO-011/NO

Rotarix

Norway

6.10.2008

EU/1/05/330/005-011

Rotarix

Liechtenstein

31.10.2008

EU/1/05/330/005-011/IS

Rotarix

Iceland

27.9.2008

EU/1/05/331/038/NO-055/NO

Neupro

Norway

25.9.2008

EU/1/05/331/038-055

Neupro

Liechtenstein

31.10.2008

EU/1/05/331/038-055/IS

Neupro

Iceland

15.10.2008

EU/1/06/343/006-007

Baraclude

Liechtenstein

31.8.2008

EU/1/06/356/007-009

Exjade

Liechtenstein

31.12.2008

EU/1/06/360/012

Champix

Liechtenstein

31.8.2008

EU/1/06/368/088/NO-142/NO

Insulin Human Winthrop

Norway

28.11.2008

EU/1/06/368/088-142

Insulin Human Winthrop

Liechtenstein

31.12.2008

EU/1/07/386/011-012

Toviaz

Liechtenstein

31.8.2008

EU/1/07/386/013-016

Toviaz

Liechtenstein

31.12.2008

EU/1/07/392/002

Circadin

Liechtenstein

31.8.2008

EU/1/07/394/007-009

Optaflu

Liechtenstein

31.8.2008

EU/1/07/400/017/NO-021/NO

Mircera

Norway

13.10.2008

EU/1/07/400/017-020/IS

Mircera

Iceland

17.10.2008

EU/1/07/400/017-021

Mircera

Liechtenstein

31.10.2008

EU/1/07/410/017-020

Binocrit

Liechtenstein

31.8.2008

EU/1/07/411/017-020

Epoetin alfa Hexal

Liechtenstein

31.8.2008

EU/1/07/412/017-020

Abseamed

Liechtenstein

31.8.2008

EU/1/07/414/018

Galvus

Liechtenstein

31.10.2008

EU/1/07/419/010-012

Cervarix

Liechtenstein

31.12.2008

EU/1/07/431/020/NO-025/NO

Retacrit

Norway

15.12.2008

EU/1/07/431/020-025

Retacrit

Liechtenstein

31.12.2008

EU/1/07/432/020-022

Silapo

Liechtenstein

31.8.2008

EU/1/95/003/007/NO-008/NO

Betaferon

Norway

13.11.2008

EU/1/95/003/007-008

Betaferon

Liechtenstein

31.12.2008

EU/1/97/030/140/NO-169/NO

Insuman

Norway

1.12.2008

EU/1/97/030/140-169

Insuman

Liechtenstein

31.12.2008

EU/102/206/021/NO-035/NO

Arixtra

Norway

8.9.2008

EU/102/206/021-035

Arixtra

Liechtenstein

31.10.2008

EU/2/02/033/002

Dexdomitor

Liechtenstein

31.8.2008

EU/2/05/054/018/NO-031/NO

Profender

Norway

24.9.2008

EU/2/05/054/018-031

Profender

Liechtenstein

31.10.2008

EU/2/05/054/018-031/IS

Profender

Iceland

1.10.2008

EU/2/06/058/004

Flexicam

Liechtenstein

31.12.2008

EU/2/99/015/002

Oxyglobin

Liechtenstein

31.10.2008

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July-31 December 2008:

| EU-Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/01/184/001-073 | Nespo | Liechtenstein | 31.12.2008 |
| EU/1/01/185/023-030 | Aranesp | Liechtenstein | 31.12.2008 |
| EU/1/02/202/001-006 | Protopy | Liechtenstein | 31.10.2008 |
| EU/1/02/202/001-006/IS | Protopy | Iceland | 27.9.2008 |
| EU/1/02/228/001-003 | Neupopeg | Liechtenstein | 31.12.2008 |
| EU/1/04/293/001-012 | Parareg | Liechtenstein | 31.12.2008 |
| EU/1/04/301/001/NO-005/NO | Quintanrix | Norway | 25.11.2008 |
| EU/1/04/301/001-005 | Quintanrix | Liechtenstein | 31.10.2008 |
| EU/1/04/301/001-005/IS | Quintanrix | Iceland | 27.9.2008 |
| EU/1/05/327/001/NO-018/NO | Exubera | Norway | 25.11.2008 |
| EU/1/05/327/001-018 | Exubera | Liechtenstein | 31.10.2008 |
| EU/1/05/327/001-018/IS | Exubera | Iceland | 22.10.2008 |
| EU/1/98/093/002 | Forcaltonin | Liechtenstein | 31.12.2008 |
| EU/1/98/093/002/IS | Forcaltonin | Iceland | 29.11.2008 |
| EU/1/98/093/002/NO | Forcaltonin | Norway | 25.11.2008 |
| EU/1/99/128/001/NO-037/NO | Viraferon | Norway | 29.10.2008 |
| EU/1/99/128/001-037 | Viraferon | Liechtenstein | 31.10.2008 |
| EU/1/99/128/001-037/IS | Viraferon | Iceland | 22.10.2008 |

EU-Number

Product

Country

Date of withdrawal

EU/1/01/184/001-073

Nespo

Liechtenstein

31.12.2008

EU/1/01/185/023-030

Aranesp

Liechtenstein

31.12.2008

EU/1/02/202/001-006

Protopy

Liechtenstein

31.10.2008

EU/1/02/202/001-006/IS

Protopy

Iceland

27.9.2008

EU/1/02/228/001-003

Neupopeg

Liechtenstein

31.12.2008

EU/1/04/293/001-012

Parareg

Liechtenstein

31.12.2008

EU/1/04/301/001/NO-005/NO

Quintanrix

Norway

25.11.2008

EU/1/04/301/001-005

Quintanrix

Liechtenstein

31.10.2008

EU/1/04/301/001-005/IS

Quintanrix

Iceland

27.9.2008

EU/1/05/327/001/NO-018/NO

Exubera

Norway

25.11.2008

EU/1/05/327/001-018

Exubera

Liechtenstein

31.10.2008

EU/1/05/327/001-018/IS

Exubera

Iceland

22.10.2008

EU/1/98/093/002

Forcaltonin

Liechtenstein

31.12.2008

EU/1/98/093/002/IS

Forcaltonin

Iceland

29.11.2008

EU/1/98/093/002/NO

Forcaltonin

Norway

25.11.2008

EU/1/99/128/001/NO-037/NO

Viraferon

Norway

29.10.2008

EU/1/99/128/001-037

Viraferon

Liechtenstein

31.10.2008

EU/1/99/128/001-037/IS

Viraferon

Iceland

22.10.2008

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July-31 December 2008:

| EU-Number | Product | Country | Date of suspension |
| --- | --- | --- | --- |
| EU/1/06/344/001-011 | Acomplia | Liechtenstein | 31.12.2008 |
| EU/1/06/344/001-011/IS | Acomplia | Iceland | 26.11.2008 |
| EU/1/06/345/001-011 | Zimulti | Liechtenstein | 31.12.2008 |
| EU/1/06/345/001-011/IS | Zimulti | Iceland | 26.11.2008 |

EU-Number

Product

Country

Date of suspension

EU/1/06/344/001-011

Acomplia

Liechtenstein

31.12.2008

EU/1/06/344/001-011/IS

Acomplia

Iceland

26.11.2008

EU/1/06/345/001-011

Zimulti

Liechtenstein

31.12.2008

EU/1/06/345/001-011/IS

Zimulti

Iceland

26.11.2008

---